Moneycontrol PRO
Open App
you are here: HomeNewsIndia

Coronavirus Omicron Update | India logs highest single day rise of Omicron cases, tally climbs to 578

Coronavirus Omicron Update | The ministry said 151 out of the 578 people who contracted the infection have recovered or migrated.

December 27, 2021 / 10:14 AM IST
(Representative image: AP)

(Representative image: AP)

India saw the highest single day rise of Omicron infections with 156 fresh cases, taking the total tally of such cases to 578, according to the Union Health Ministry data updated on Monday.

The ministry said 151 out of the 578 people who contracted the infection have recovered or migrated.

The 578 cases have been detected across 19 states and UTs with Delhi recording the maximum number of 142 cases followed by Maharashtra at 141, Kerala 57, Gujarat 49, Rajasthan 43 and Telangana 41.

With 6,531 people testing positive for coronavirus infections in a day India’s total tally of COVID-19 cases rose to 3,47,93,333, while the active cases declined to 75,841, according to the data updated at 8 am.

The death toll has climbed to 4,79,997 with 315 fresh fatalities, the data stated. The daily rise in new coronavirus infections has been recorded below 15,000 for the last 60 days now.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The active cases have declined to 75,841 comprising 0.22 per cent of the total infections, the lowest since March 2020, while the national COVID-19 recovery rate was recorded at 98.40 per cent, the highest since March 2020, the ministry said.

A decrease of 925 cases has been recorded in the active COVID-19 caseload in a span of 24 hours. India’s COVID-19 tally had crossed the 20-lakh mark on August 7, 2020, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16.

It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19. India crossed the grim milestone of two crore on May 4 and three crore on June 23.

(With PTI inputs)
Moneycontrol News
first published: Dec 27, 2021 10:17 am
Sections
ISO 27001 - BSI Assurance Mark